Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Hilary Baldwin MD

Hilary E. Baldwin MD

Medical Director, The Acne Treatment and Research Center, Brooklyn, New York; Clinical Associate Professor, Department of Dermatology, Rutgers Robert Wood Johnson Medical Center, New Brunswick, New Jersey

Hilary Baldwin is a board-certified dermatologist and medical director of the Acne Treatment & Research Center in Brooklyn, New York.  She is a clinical associate professor of dermatologist at Rutgers Robert Wood Johnson Medical Center. Dr. Baldwin has interests in acne, rosacea, keloidal scarring, cosmeceuticals and the skin microbiome. She is a frequent national and international lecturer and visiting professor, and her work has been published extensively in dermatology journals. Dr. Baldwin served as a founding board member and second president of the American Acne and Rosacea Society.

Disclosures

Dr. Baldwin is on the speaker’s bureau for SUN Pharma.

Recent Contributions to PracticeUpdate:

  1. E-Visits for Isotretinoin Management Have No Effect on Interruptions in Care
  2. Barriers to Isotretinoin Treatment for Acne Vulgaris in Children and Adolescents
  3. Nonpharmacological Therapies May Be Potential Alternatives in the Treatment of Acne Vulgaris
  4. Pregnancy Prevention on Isotretinoin: Practical Recommendations

Most Read This Week

Recently Updated